---
title: "Opipramol - Depressive Disorder"
sidebar: mydoc_sidebar
permalink: db12930-mesh-d003866-1.html
toc: false 
---


Path ID: `DB12930_MESH_D003866_1`
{% include image.html url="images/db12930-mesh-d003866-1.png" file="db12930-mesh-d003866-1.png" alt="db12930-mesh-d003866-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D009888 | Opipramol | Drug |
| UniProt:Q99720 | Sigma non-opioid intracellular receptor 1 | Protein |
| GO:0007269 | Neurotransmitter secretion | BiologicalProcess |
| MESH:D003866 | Depressive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Opipramol | INCREASES ACTIVITY OF | Sigma Non-Opioid Intracellular Receptor 1 |
| Sigma Non-Opioid Intracellular Receptor 1 | POSITIVELY REGULATES | Neurotransmitter Secretion |
| Neurotransmitter Secretion | TREATS | Depressive Disorder |
|---------|-----------|---------|

Comment: Higher doses of opipramol are needed for anti-depressant effect.

Reference: 
  - [https://en.wikipedia.org/wiki/Opipramol](https://en.wikipedia.org/wiki/Opipramol)
  - [https://pubmed.ncbi.nlm.nih.gov/15547785/](https://pubmed.ncbi.nlm.nih.gov/15547785/)
  - [https://www.researchgate.net/publication/259936188_OPIPRAMOL_A_NOVEL_DRUG](https://www.researchgate.net/publication/259936188_OPIPRAMOL_A_NOVEL_DRUG)
